Alaska Air Group (NYSE:ALK) is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $55.00 price target on the stock. This represents a 19.8% upside from the current price of $45.90. |
(BIOA) (NYSE:BIOA) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $45.00 price target on the stock. This represents a 88.6% upside from the current price of $23.86. |
(BIOA) (NYSE:BIOA) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $40.00 price target on the stock. This represents a 67.6% upside from the current price of $23.86. |
(BIOA) (NYSE:BIOA) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $42.00 price target on the stock. This represents a 76.0% upside from the current price of $23.86. |
BKV (NYSE:BKV) is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $24.00 price target on the stock. This represents a 29.4% upside from the current price of $18.55. |
BKV (NYSE:BKV) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $28.00 price target on the stock. This represents a 50.9% upside from the current price of $18.55. |
BKV (NYSE:BKV) is now covered by analysts at Mizuho. They set an “outperform” rating and a $29.00 price target on the stock. This represents a 56.3% upside from the current price of $18.55. |
BKV (NYSE:BKV) is now covered by analysts at Evercore ISI. They set an “outperform” rating and a $24.00 price target on the stock. This represents a 29.4% upside from the current price of $18.55. |
BKV (NYSE:BKV) is now covered by analysts at KeyCorp. They set an “overweight” rating and a $23.00 price target on the stock. This represents a 24.0% upside from the current price of $18.55. |
BKV (NYSE:BKV) is now covered by analysts at Citigroup Inc.. They set a “buy” rating and a $29.00 price target on the stock. This represents a 56.3% upside from the current price of $18.55. |
Capricor Therapeutics (NASDAQ:CAPR) is now covered by analysts at Piper Sandler. They set an “overweight” rating and a $35.00 price target on the stock. This represents a 79.0% upside from the current price of $19.55. |
CyberArk Software (NASDAQ:CYBR) is now covered by analysts at Scotiabank. They set a “sector outperform” rating and a $340.00 price target on the stock. This represents a 13.7% upside from the current price of $298.98. |
DTE Energy (NYSE:DTE) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $137.00 price target on the stock. This represents a 7.3% upside from the current price of $127.71. |
Eagle Bancorp (NASDAQ:EGBN) is now covered by analysts at Piper Sandler. They set a “neutral” rating and a $27.00 price target on the stock. This represents a 14.8% upside from the current price of $23.51. |
Elme Communities (NYSE:ELME) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $16.69. |
ESCO Technologies (NYSE:ESE) is now covered by analysts at Benchmark Co.. They set a “buy” rating and a $150.00 price target on the stock. This represents a 18.2% upside from the current price of $126.93. |
GE Vernova (NYSE:GEV) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $354.00 price target on the stock. This represents a 29.8% upside from the current price of $272.75. |
Guardian Pharmacy Services (NYSE:GRDN) is now covered by analysts at Truist Financial Co.. They set a “buy” rating and a $22.00 price target on the stock. This represents a 25.0% upside from the current price of $17.60. |
Guardian Pharmacy Services (NYSE:GRDN) is now covered by analysts at Raymond James. They set an “outperform” rating and a $21.00 price target on the stock. This represents a 19.3% upside from the current price of $17.60. |
Harmony Gold Mining (NYSE:HMY) is now covered by analysts at Bank of America Co.. They set a “neutral” rating on the stock.The current price is $11.99. |
Hormel Foods (NYSE:HRL) is now covered by analysts at BNP Paribas. They set an “underperform” rating and a $28.00 price target on the stock. This represents a 11.1% downside from the current price of $31.48. |
INmune Bio (NASDAQ:INMB) is now covered by analysts at Alliance Global Partners. They set a “buy” rating and a $20.00 price target on the stock. This represents a 296.8% upside from the current price of $5.04. |
Korro Bio (NASDAQ:KRRO) is now covered by analysts at Raymond James. They set a “strong-buy” rating and a $153.00 price target on the stock. This represents a 96.5% upside from the current price of $77.85. |
Perfumania (NASDAQ:PERF) is now covered by analysts at Noble Financial. They set an “outperform” rating and a $5.00 price target on the stock. This represents a 157.7% upside from the current price of $1.94. |
Arcus Biosciences (NYSE:RCUS) is now covered by analysts at HC Wainwright. They set a “neutral” rating and a $20.00 price target on the stock. This represents a 20.0% upside from the current price of $16.67. |
Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Guggenheim. They set a “buy” rating and a $70.00 price target on the stock. This represents a 39.4% upside from the current price of $50.23. |
Similarweb (NYSE:SMWB) is now covered by analysts at Needham & Company LLC. They set a “buy” rating and a $11.00 price target on the stock. This represents a 19.0% upside from the current price of $9.24. |
Sarepta Therapeutics (NASDAQ:SRPT) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $165.00 price target on the stock. This represents a 29.3% upside from the current price of $127.63. |